x

Search for an orphan drug

*(*) mandatory field

Other search option(s)

Lintuzumab

   
  • INN (International Nonproprietary Name) : -
  • Code name : -
  • Chemical name or description : -
  • Type of product : Ingredient/substance
  • Type of production : Biotechnology
  • Orphan designation : EuropeUSA
    • Orphan designation  - USA

    • Diseases list
      • Refractory anemia
      • Aregenerative anemia
      • Myelodysplastic syndrome
      • Refractory anemia with excess blasts
      • Unclassified myelodysplastic syndrome
      • Acquired idiopathic sideroblastic anemia
      • Refractory cytopenia with multilineage dysplasia
      • Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
    • Detailed information
    • Orphan designation  - USA

    • Diseases list
      • Acute myeloid leukemia
      • Acute erythroid leukemia
      • Acute promyelocytic leukemia
      • Acute myelomonocytic leukemia
      • Acute megakaryoblastic leukemia
      • Acute panmyelosis with myelofibrosis
      • Acute myeloid leukaemia with myelodysplasia-related features
      • Therapy related acute myeloid leukemia and myelodysplastic syndrome
    • Detailed information

Additional information

Research on this medical product

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.